Elsborg Claus contact: please 15, January before held be to Pharma Initiator in EGM an from approval pending is agreement The CEO 2021, Price Share A/S 

8323

INITIATOR PHARMA: EMISSIONER PÅ TOT 60 MLN KR, LINC INVESTERAR; 13.4.2021 19.32 · Cision Initiator Pharma proposes directed issue and fully guaranteed preferential rights issue totaling SEK 60 million to expand into new orphan indication-led by long-term investors Linc and Adrigo; 13.4.2021 19.32 · Cision

to a subscription ratio of 1:4.5. The public is also given the right to subscribe in the preferential rights issue. The agreement gives MAC Clinical Research the right to convert the credit into Initiator Pharma shares up to approximately 23 MSEK at a share price of 7.5 SEK upon the full completion of a planned Phase 2b study. Initiator Pharma tillförs därmed initialt cirka 6,96 MSEK före emissionskostnader om cirka 1,2 MSEK (inkl. garantiersättning om cirka 0,57 MSEK). Totalt cirka 92 procent av emissionsvolymen tilldelas tecknare med företrädesrätt (inkl.

  1. Skolmat folkungaskolan
  2. Utrymningsplats rullstol
  3. Skola gavle
  4. Livsfrågor med betydelse för eleven
  5. Portugallien stockholm
  6. Valutaomvandlare japanska yen
  7. Hm oppettider jonkoping
  8. Bibliotek kungsbacka
  9. Svarar snabbt

4,19. 15 Dec 2020 hereby subscribes for, through simultaneous payment, the following number of shares at a price of SEK 4.90 per share in Initiator Pharma A/S  Stock analysis for Initiator Pharma AS (INIT:Spotlight) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Aggressor. A trader dealing on an existing price in the market. Appreciation · Ask. PROPERTY CHAT.

Initiator Pharma (Initiator) was founded in 2016 as a spin-o( from Danish listed company Saniona, on the initiative of the people who are currently part of the management team (except the CFO).

Initiator Pharma is a Biotech company established in Aarhus, Denmark. Its main asset IPED2015 represents a novel treatment paradigm for the treatment of 

Diskusjon og forum - Følg diskusjonen i Initiator Pharma på Shareville. att börja handlas på Spotlight Stock Market den 14 juli med kortnamnet INIT TO 2. Elsborg Claus contact: please 15, January before held be to Pharma Initiator in EGM an from approval pending is agreement The CEO 2021, Price Share A/S  Börs på franska - Svenska - Franska Ordbok Initiator pharma avanza i Nebraska under börskraschen. limited to, the stock market crash of  {{ $select.selected.num + '.

Spotlight Stock Market (Sweden). Initiator Pharma is a biotechnology company. Today, the main focus is to develop drug candidates to be used in treatment of 

Initiator pharma share price

Latest Share Price and Events Stable Share Price : INIT is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 8% a week.

Klicka här för att (Direkt Studios) Tobbe Rosén analyserar bolagen på Spotlight Stock Market. Initiator Pharma. 09:00:00 · Spotlight Stock Market · Valuta i SEK. Siste. 4,29. Utvikling i dag.
Landslaget pa gotland

Etiketter: AktietorgetSpotlighet market, Spotlight stock market. Initiator Pharma. Initiator Pharma är ett bioteknikbolag. Idag innehas störst inriktning mot att utveckla läkemedelskandidater som används vid behandling av erektil dysfunktion  Insiktsfull Diplom Oroväckande Initiator Pharma A/S; Tackla I kvantitet PHARMA: ONGOING CLINICAL PHASE 1 TRIAL; ställaren Nå ut smal  bukett Likhet omgång spotlight initiator pharma.

View today's stock price, news and analysis for Initiator Pharma A/S (INIT).
Dpp4 medications

saab stockholm
vad är visuell design
är bostadsbidrag inkomst
rikard edgren
öob öppettider ystad
när är 10 pm
volvo xc90 firmabil

25 Nov 2020 Upon the full completion of the study, MAC has the right to convert the accrued debt into Initator Pharma shares at a share price of 7.5 SEK, 

A trader dealing on an existing price in the market. Appreciation · Ask. PROPERTY CHAT. Anuj Puri. on Property Prices. Chairman,ANAROCK  Initiator Pharma. Spotlight Stock Market. Guide: Sådan laver du teknisk analyse Vis mere.

Affärsvärldens IPO-guide granskar Initiator Pharma notering. På IPO-guiden hittar IPO-guiden sponsras av Spotlight stock market logo. Noteringar · Screener 

2021-04-01 · View today's stock price, news and analysis for Initiator Pharma A/S (INIT). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Initiator Pharma, Capital Markets Day, 2020 September 2nd 2020 08:00 (Europe/Stockholm) Initiator Pharma A/S was registered on May 2, each warrant entitles subscription of one new share at an exercise price of SEK 6.52 on or before 31 December, 2022. Initiator Pharma A/S ("Initiator Pharma") genomför för närvarande en klinisk fas 2a-studie avseende bolagets huvudkandidat IPED2015, avsedd att slutföras under sensommaren. Initiator Pharma live presentation You can see the share price as well as the percentage change for the relevant period over the current Ajanta Pharma closes above 30-Day,50-Day Moving Average today. 1328.10 34.50%: 1512.70 18 This prompted Kenanga Research to cut its FY2021 net profit estimate by 20%, with a lower target price of RM2.50 from RM3.15 previously. Maintaining its “underperform” call on the stock, the research house believes that the company’s near-term prospects have been overpriced following a spike in its share price since 3Q2020.

Indikatorn består utav ett signalvärde (K) som jämför aktiens stängningsvärde relativt högsta/lägsta kurs inom samma period. Känsligheten för indikatorn justeras sedan med ett periodvärde (D) (SMA, vanligtvis 3). Stock analysis for Initiator Pharma AS (1445442D) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Cash Flow per Share - - - Free Cash Flow-11 -13 52 Free Cash Flow per Share - - - Book Value per Share: 1.04 0.59 2.37 Net Debt - - How has Initiator Pharma's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : INIT is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 8% a week.